Events

Breast Cancer Risk Assessment using Genetics, Epigenetics, and all the other stuff
30 May 2013
13:30-14:30
Dr James Flanagan, Research Fellow, Division of Cancer, Imperial College London
Germline susceptibility to breast cancer
06 Jun 2013
13:30-14:30
Dr Nick Orr, Team Leader, Complex Trait Genetics Team Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London

Novel imaging probes based on C2A/Synaptotagmin-I enable specific tumour cell death detection follow
Dr Andre Neves, Principal Scientific Officer, CRUK Cambridge Research Institute
Hammersmith Campus
20 Jun 201313:30-14:30
Targeting epigenetic dependencies of tumor-initiating cells for triple-negative breast cancer therap
Dr Fabio Petrocca MD, Instructor, Harvard Medical School & Research Associate, Haematology/Oncology, Boston Children’s Hospital, USA.
Hammersmith Campus
25 Jun 201317:30-18:30
Mechanotransduction at the cadherin-actomyosin interface
Dr Johan de Rooij, Groupleader, Dynamics of cell-cell Adhesion, The Hubrecht Institute, The Netherlands
Hammersmith Campus
04 Jul 201313:30-14:30
Targeting DNA damage response in the clinic – a tale of two pathways
Professor Ruth Plummer, Clinical Professor of Experimental Cancer Medicine, Northern Institute for Cancer Research, Medical School, University of Newc
Hammersmith Campus
23 May 201313:30-14:30